athenahealth (Nasdaq:ATHN) offers another example of how it's important to separate a company from its stock. From the perspective of an operating company, there are a lot of positive things going on at this provider of software and services to medical practices. From a stock perspective, though, expectations are already red-hot and success is taken as a given, leaving little on the table for the future and significantly increasing the risk that any future earnings shortfall will be met with a painful sell-off in the shares.

Investopedia Broker Guides: Enhance your trading with the tools from today's top online brokers.

The Growth Story Remains the Same
The basic story at athenahealth hasn't changed all that much - the company needs to sign up more practices to use its athenaCollector revenue management product, while also increasing its sell-through and cross-selling efforts for platforms like Clinicals and Communicator.

As of the last quarter, the company continues to do well in that respect. Not only did the company post a 4% sequential growth in the number of physicians (22% growth year on year) and providers (21% growth year on year) using Collector, but user growth was considerably stronger in both Clinicals and Communicator. All of that helped to fuel a 38% rise in revenue, a result that was a bit ahead of generally bullish analyst expectations.

But so Does the Profitability Challenge
Although top-line growth looks great, doctors continue to sign up as customers and customer satisfaction and retention numbers remain strong, all is not perfect in athenahealth-land. Like many other software as a-service (SaaS) stories, including salesforce.com (NYSE:CRM), the cost of that growth is a more troublesome story.

Gross margin actually declined from last year on a GAAP basis, while operating income dropped. Although some investors may choose to focus on the non-GAAP measures that show growth (including a 27% growth in adjusted EBITDA), the 40% increase in sales and marketing expenses should not be ignored.

It's not enough to just pull customers away from Allscripts (Nasdaq:MDRX), General Electric (NYSE:GE), Siemens (NYSE:SI) or McKesson (NYSE:MCK), it also has to be a leveragable profit-making opportunity. While it may be unfair to compare SaaS providers across industries, and it is still early in the SaaS story, the ability to really leverage sales and marketing and post the sort of margins that traditional software and healthcare IT companies posted in the past seems like an open question.

SEE: A Look At Corporate Profit Margins

Separating Value and Shareholder Value
I don't argue that athenahealth delivers a good suite of products. The ability to update payor rules in real-time is valuable. Likewise, the ability to better manage the continuum of care, reduce errors, keep up with changes in legislation and improve care are all selling points.

Here again, though, is the difference between a "good company" and a "good stock." Penetrating larger enterprises has remained a challenge and healthcare IT is a ferociously competitive space, with more companies looking to enter the market with their own SaaS model.

The Bottom Line
On some level there's just a basic disconnect between growth and value investors. Accordingly, growth investors may well look at the reported revenue growth, increasing subscriber numbers and improving cross-sell metrics and argue that valuation is beside the point. And, at least for a while, they likely have a valid point.

Sooner or later, though, valuation always matters. Whether that's sooner (in the case of a shortfall in reported results or guidance) or later (as penetration rates reduce prospective growth rates), I do not know. But what I do know is that stocks trading at around a seven times trailing revenue are not buy-and-hold stocks, but rather buy-and-jump stocks that demand the ability to spot the point where the growth curve starts to flatten and get out before the Street and other growth investors turn on the name.

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

At the time of writing, Stephen D. Simpson did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Investing News

    Bank Stocks: Time to Buy or Avoid? (WFC, JPM, C)

    Bank stocks have been pounded. Is this the right time to buy or should they be avoided?
  2. Stock Analysis

    Why the Bullish Are Turning Bearish

    Banks are reducing their targets for the S&P 500 for 2016. Here's why.
  3. Stock Analysis

    How to Find Quality Stocks Amid the Wreckage

    Finding companies with good earnings and hitting on all cylinders in this environment, although possible, is not easy.
  4. Investing

    Adobe Systems: A Company In Transition (ADBE)

    Adobe Systems is undergoing a major change to its business model. We take a look at its strategy, challenges, and performance.
  5. Retirement

    Is it Safe for Retirees to Invest in Technology?

    Tech stocks are volatile creatures, but there are ways even risk-adverse retirees can reap rewards from them. Here are some strategies.
  6. Stock Analysis

    Company Overview: Qlogic (QLGC)

    Learn more about the world's leading manufacturer of Fibre Channel network adapters, a key component in high-speed corporate storage networks and data centers.
  7. Investing News

    What You Can Learn from Carl Icahn's Mistakes

    Carl Icahn has been a stellar performer in the investment world for decades, but following his lead these days could be dangerous.
  8. Stock Analysis

    Analyzing Altria's Return on Equity (ROE) (MO)

    Learn about Altria Group's return on equity (ROE) and analyze net profit margin, asset turnover and financial leverage to determine what is causing its high ROE.
  9. Investing

    What Investors Need to Know About Returns in 2016

    Last year wasn’t a great one for investors seeking solid returns, so here are three things we believe all investors need to know about returns in 2016.
  10. Investing News

    Icahn's Bet on Cheniere Energy: Should You Follow?

    Investing legend Carl Icahn continues to lose money on Cheniere Energy, but he's increasing his stake. Should you follow his lead?
RELATED FAQS
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
COMPANIES IN THIS ARTICLE
Trading Center